Precipio (NASDAQ:PRPO) and SBC Medical Group (NASDAQ:SBC) Critical Survey

Precipio (NASDAQ:PRPO) and SBC Medical Group (NASDAQ:SBC) are both small-cap healthcare companies, but which is the better business? We will contrast the two companies based on the strength of their earnings, risk, analyst recommendations, dividends, institutional ownership, valuation and profitability.

Earnings & Valuation

This table compares Precipio and SBC Medical Group”s top-line revenue, earnings per share and valuation.

	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Precipio	$24.05 million	1.97	-$360,000.00	($0.64)	-41.31
SBC Medical Group	$173.61 million	2.57	$50.99 million	$0.47	9.24

SBC Medical Group has higher revenue and earnings than Precipio. Precipio is trading at a lower price-to-earnings ratio than SBC Medical Group, indicating that it is currently the more affordable of the two stocks.

Analyst Ratings

This is a summary of recent ratings and recommmendations for Precipio and SBC Medical Group, as reported by MarketBeat.

	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Precipio	1	0	0	0	1.00
SBC Medical Group	1	0	2	0	2.33

SBC Medical Group has a consensus price target of $8.50, indicating a potential upside of 95.63%. Given SBC Medical Group’s stronger consensus rating and higher possible upside, analysts clearly believe SBC Medical Group is more favorable than Precipio.

Institutional and Insider Ownership

10.4% of Precipio shares are owned by institutional investors. Comparatively, 60.8% of SBC Medical Group shares are owned by institutional investors. 16.6% of Precipio shares are owned by insiders. Comparatively, 81.7% of SBC Medical Group shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term.

Risk & Volatility

Precipio has a beta of 1.32, meaning that its stock price is 32% more volatile than the S&P 500. Comparatively, SBC Medical Group has a beta of 0.63, meaning that its stock price is 37% less volatile than the S&P 500.

Profitability

This table compares Precipio and SBC Medical Group’s net margins, return on equity and return on assets.

	Net Margins	Return on Equity	Return on Assets
Precipio	-4.47%	-8.49%	-5.75%
SBC Medical Group	27.99%	18.47%	13.10%

Summary

SBC Medical Group beats Precipio on 13 of the 14 factors compared between the two stocks.

About Precipio

Precipio, Inc., a healthcare solutions company, provides diagnostic products, reagents, and services in the United States. It provides diagnostic blood cancer testing services. The company offers IV-Cell, a proprietary cell culture media that enables simultaneous culturing of four hematopoietic cell lineages; and HemeScreen, a suite of robust genetic diagnostic panels. It offers biomarker testing and clinical project services to bio-pharma customers. The company is based in New Haven, Connecticut.

About SBC Medical Group

SBC Medical Group Holdings Incorporated, through its subsidiaries, provides services to support the operation of clinics which deliver specialized medical services in the areas of cosmetic medicine, esthetic dentistry and Androgenetic Alopecia or AGA, primarily in Japan and centered on the SBC Shonan Beauty Clinic Brand. SBC Medical Group Holdings Incorporated, formerly known as Pono Capital Two Inc., is based in TOKYO.